Stimulation of Na-dependent phosphate transport by platelet-derived growth factor in rat aortic smooth muscle cells

Atherosclerosis

Volumn 174, Issue 1, 2004, Pages 17-24

  Kakita, Ayako ^a   Suzuki, Atsushi ^b   Nishiwaki, Keiko ^a   Ono, Yasunaga ^b   Kotake, Motoko ^b   Ariyoshi, Yoh ^a   Miura, Yoshitaka ^a   Ltoh, Mitsuyasu ^b   Oiso, Yutaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Inorganic phosphate transport; PDGF; Protein kinase C; S6 kinase; Vascular smooth muscle cells

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CALPHOSTIN C; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE B; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE; RAPAMYCIN; S6 KINASE; SODIUM; TRANSCRIPTION FACTOR PIT 1;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOWN REGULATION; HEART ATRIUM; HEART MUSCLE CELL; ION TRANSPORT; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; BLOTTING, NORTHERN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; MODELS, ANIMAL; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; PROBABILITY; PROTEIN KINASE C; RATS; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SODIUM;

EID: 2342523148     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2003.12.039     Document Type: Article

References (31)

1. Lusis A.J. Atherosclerosis. Nature. 407:2000;233-241
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809
3. Ross R., Raines E.W., Bowen-Pope D.F. The biology of platelet-derived growth factor. Cell. 46:1986;155-169
4. Negoro N., Kanayama Y., Haraguchi M., et al. Blood pressure regulates platelet-derived growth factor A-chain gene expression in vascular smooth muscle cells in vivo. An autocrine mechanism promoting hypertensive vascular hypertrophy. J. Clin. Invest. 95:1995;1140-1150
5. 2+ in activation of mitogen-activated protein kinase and DNA synthesis in vascular smooth muscle cells. J. Hypertens. 15:1997;1671-1675
6. Pukac L., Huangpu J., Kamovsky M.J. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration. Exp. Cell Res. 242:1998;548-560
7. Heldin C.H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79:1999;1283-1316
8. Berridge M.J. Inositol trisphosphate and calcium signaling. Ann. N. Y. Acad. Sci. 766:1995;31-43
9. Nishizuka Y. Studies and perspectives of protein kinase C. Science. 233:1986;305-312
10. Pearson G., Robinson F., Beers Gibson T., et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22:2001;153-183
11. Chan T.O., Rittenhouse S.E., Tsichlis P.N. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide- dependent phosphorylation. Ann. Rev. Biochem. 68:1999;965-1014
12. Bai H., Pollman M.J., Inishi Y., Gibbons G.H. Regulation of vascular smooth muscle cell apoptosis. Modulation of bad by a phosphatidy linositol 3-kinase-dependent pathway. Circ. Res. 85:1999;229-237
13. Jono S., Mckee M.D., Murry C.E., et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ. Res. 87:2000;10-17
14. Takeda E., Taketani Y., Morita K., et al. Molecular mechanisms of mammalian inorganic phosphate homeostasis. Adv. Enzyme Regul. 40:2000;285-302
15. Kavanaugh M.P., Kabat D. Identification and characterization of a widely expressed phosphate transporter/retrovirus receptor family. Kidney Int. 49:1996;959-963
16. Caverzasio J., Montessuit C., Bonjour J.P. Functional role of Pi transport in osteogenic cells. News Physiol. Sci. 11:1996;119-125
17. Montessuit C., Bonjour J.P., Caverzasio J. Expression and regulation of Na-dependent Pi transport in matrix vesicles produced by osteoblast-like cells. J. Bone Miner Res. 10:1995;625-631
18. Palmer G., Bonjour J.P., Caverzasio J. Expression of a newly identified phosphate transporter/retrovirus receptor in human SaOS-2 osteoblast-like cells and its regulation by insulin-like growth factor I. Endocrinology. 138:1997;5202-5209
19. Palmer G., Guicheux J., Bonjour J.P., Caverzasio J. Transforming growth factor-beta stimulates inorganic phosphate transport and expression of the type III phosphate transporter Glvr-1 in chondrogenic ATDC5 cells. Endocrinology. 141:2000;2236-2243
20. Suzuki A., Palmer G., Bonjour J.P., Caverzasio J. Stimulation of sodium-dependent phosphate transport and signaling mechanisms induced by basic fibroblast growth factor in MC3T3-E1 osteoblast-like cells. J. Bone Miner. Res. 15:2000;95-102
21. Kovalenko M., Gazit A., Bohmer A., et al. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res. 54:1994;6106-6114
22. Murakami Y., Fukazawa H., Mizuno S., Uehara Y. Effect of herbimycin A on tyrosine kinase receptors and platelet derived growth factor (PDGF)-induced signal transduction. Biol. Pharm. Bull. 21:1998;1030-1035
23. Kobayashi E., Nakano H., Morimoto M., Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159:1989;548-553
24. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 298:2002;1911-1912
25. Favata M.F., Horiuchi K.Y., Manos E.J., et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:1998;18623-18632
26. Cuenda A., Rouse J., Doza Y.N., et al. SB 203580 is a specific inhibitor of MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:1995;229-233
27. Bennett B.L., Sasaki D.T., Murray B.W., et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 98:2001;13681-13686
28. + exchange by platelet-derived growth factor involves phosphatidylinositol 3′-kinase and phospholipase C gamma. J. Biol. Chem. 269:1994;30734-30739
29. Vlahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294402). J. Biol. Chem. 269:1994;5241-5248
30. Terada N., Franklin R.A., Lucas J.J., Blenis J., Gelfand E.W. Failure of rapamycin to block proliferation once resting cells have entered the cell cycle despite inactivation of p70 S6 kinase. J. Biol. Chem. 268:1993;12062-12068
31. Zou Y., Hu Y., Metzler B., Xu Q. Signal transduction in arteriosclerosis: mechanical stress-activated MAP kinases in vascular smooth muscle cells (review). Int. J. Mol. Med. 1:1998;827-834